![]() | |
![]() | |
Clinical data | |
---|---|
Other names | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C7H9N2O2 |
Molar mass | 153.161 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]
![]() | |
![]() | |
Clinical data | |
---|---|
Other names | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
Routes of administration | Oral |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard ( EPA) | |
Chemical and physical data | |
Formula | C7H9N2O2 |
Molar mass | 153.161 g·mol−1 |
3D model ( JSmol) | |
| |
| |
![]() ![]() |
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]